| Tilok Ghose, MD | |
|
7920 Old Cedar Ave S, Bloomington, MN 55425-1207 | |
| (952) 428-1800 | |
| Not Available |
| Full Name | Tilok Ghose |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 42 Years |
| Location | 7920 Old Cedar Ave S, Bloomington, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174554638 | NPI | - | NPPES |
| 339585200 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 34309 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aspirus Riverview Hospital & Clinics Inc | Wisconsin rapids, WI | Hospital |
| Glencoe Regional Health Services | Glencoe, MN | Hospital |
| Hutchinson Health | Hutchinson, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aspirus Medical Group Inc | 1052223625 | 212 |
| Aspirus Riverview Hospital And Clinics Inc | 4587658182 | 144 |
News Archive
Differences in the genetic make-up of our brains may account for the particular food preferences people have and their varying ability to stick to diets, according to new research.
Ramucirumab plus docetaxel improves progression-free survival in patients with advanced or metastatic urothelial cancer who have progressed on platinum-based chemotherapy, according to late-breaking results from the phase III RANGE trial presented today at the ESMO 2017 Congress in Madrid to be published in The Lancet.
Women who use hormone therapy before the age of 65 could cut their risk of developing Alzheimer's disease or dementia.
Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions including Colorado State University and Fred Hutchinson Cancer Center reported results today from a glioblastoma study in which they validated a biomarker indicative of a patient's prognosis and likely response to specific therapies.
› Verified 1 days ago
| Entity Name | Aspirus Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669595294 PECOS PAC ID: 1052223625 Enrollment ID: O20031103000267 |
News Archive
Differences in the genetic make-up of our brains may account for the particular food preferences people have and their varying ability to stick to diets, according to new research.
Ramucirumab plus docetaxel improves progression-free survival in patients with advanced or metastatic urothelial cancer who have progressed on platinum-based chemotherapy, according to late-breaking results from the phase III RANGE trial presented today at the ESMO 2017 Congress in Madrid to be published in The Lancet.
Women who use hormone therapy before the age of 65 could cut their risk of developing Alzheimer's disease or dementia.
Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions including Colorado State University and Fred Hutchinson Cancer Center reported results today from a glioblastoma study in which they validated a biomarker indicative of a patient's prognosis and likely response to specific therapies.
› Verified 1 days ago
| Entity Name | Aspirus Rhinelander & Tomahawk Hospitals & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144991340 PECOS PAC ID: 9335059856 Enrollment ID: O20031126000706 |
News Archive
Differences in the genetic make-up of our brains may account for the particular food preferences people have and their varying ability to stick to diets, according to new research.
Ramucirumab plus docetaxel improves progression-free survival in patients with advanced or metastatic urothelial cancer who have progressed on platinum-based chemotherapy, according to late-breaking results from the phase III RANGE trial presented today at the ESMO 2017 Congress in Madrid to be published in The Lancet.
Women who use hormone therapy before the age of 65 could cut their risk of developing Alzheimer's disease or dementia.
Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions including Colorado State University and Fred Hutchinson Cancer Center reported results today from a glioblastoma study in which they validated a biomarker indicative of a patient's prognosis and likely response to specific therapies.
› Verified 1 days ago
| Entity Name | Aspirus Riverview Hospital & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295754844 PECOS PAC ID: 4587658182 Enrollment ID: O20040414000945 |
News Archive
Differences in the genetic make-up of our brains may account for the particular food preferences people have and their varying ability to stick to diets, according to new research.
Ramucirumab plus docetaxel improves progression-free survival in patients with advanced or metastatic urothelial cancer who have progressed on platinum-based chemotherapy, according to late-breaking results from the phase III RANGE trial presented today at the ESMO 2017 Congress in Madrid to be published in The Lancet.
Women who use hormone therapy before the age of 65 could cut their risk of developing Alzheimer's disease or dementia.
Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions including Colorado State University and Fred Hutchinson Cancer Center reported results today from a glioblastoma study in which they validated a biomarker indicative of a patient's prognosis and likely response to specific therapies.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tilok Ghose, MD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-5000 | Tilok Ghose, MD 7920 Old Cedar Ave S, Bloomington, MN 55425-1207 Ph: (952) 428-1800 |
News Archive
Differences in the genetic make-up of our brains may account for the particular food preferences people have and their varying ability to stick to diets, according to new research.
Ramucirumab plus docetaxel improves progression-free survival in patients with advanced or metastatic urothelial cancer who have progressed on platinum-based chemotherapy, according to late-breaking results from the phase III RANGE trial presented today at the ESMO 2017 Congress in Madrid to be published in The Lancet.
Women who use hormone therapy before the age of 65 could cut their risk of developing Alzheimer's disease or dementia.
Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions including Colorado State University and Fred Hutchinson Cancer Center reported results today from a glioblastoma study in which they validated a biomarker indicative of a patient's prognosis and likely response to specific therapies.
› Verified 1 days ago
Jeffrey J Mair, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 Northland Dr, Bloomington, MN 55431 Phone: 952-831-8742 | |
Ryan T Morgan, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 Northland Dr, Bloomington, MN 55431 Phone: 952-831-8742 Fax: 952-831-1626 | |
Michael R Walsh, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 Northland Dr, Bloomington, MN 55431 Phone: 952-831-8742 | |
Dr. Mark Christopher Wilczynski, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 Northland Dr, Bloomington, MN 55431 Phone: 952-831-8742 Fax: 952-831-1626 | |
Mark K Thomas, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 Northland Dr, Bloomington, MN 55431 Phone: 952-831-8742 Fax: 952-831-1626 | |
Yvonne Grierson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 Northland Dr, Bloomington, MN 55431 Phone: 952-831-8742 |